Which stocks are moving on Monday? Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
FDA Raises Manufacturing Concerns, Delays Unicycive's Kidney Disease Drug Approval FDA denies Unicycive's NDA for Oxylanthanum Carbonate due to vendor issues; company eyes quick resolution with alternate manufacturer in place.
Gapping stocks in Monday's session The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Get insights into the top gainers and losers of Monday's pre-market session. Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Get insights into the top gainers and losers of Tuesday's pre-market session. Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Which stocks are moving on Tuesday? Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Unicycive Therapeutics Stock Is Trading Lower Tuesday: What's Going On? Unicycive announced update on its NDA for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease on dialysis.
Which stocks are gapping on Tuesday? Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
These stocks that are showing activity before the opening bell on Tuesday. Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
These stocks are moving in today's after hours session Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics.
UNCY Stock Earnings: Unicycive Therapeutics Beats EPS for Q2 2024 UNCY stock results show that Unicycive Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week!
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q1 2024 UNCY stock results show that Unicycive Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
